U.S. flag

An official website of the United States government

NM_014874.4(MFN2):c.1126A>G (p.Met376Val) AND Charcot-Marie-Tooth disease type 2A2

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 22, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002051828.9

Allele description [Variation Report for NM_014874.4(MFN2):c.1126A>G (p.Met376Val)]

NM_014874.4(MFN2):c.1126A>G (p.Met376Val)

Gene:
MFN2:mitofusin 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.22
Genomic location:
Preferred name:
NM_014874.4(MFN2):c.1126A>G (p.Met376Val)
HGVS:
  • NC_000001.11:g.12002069A>G
  • NG_007945.1:g.26889A>G
  • NM_001127660.2:c.1126A>G
  • NM_014874.4:c.1126A>GMANE SELECT
  • NP_001121132.1:p.Met376Val
  • NP_055689.1:p.Met376Val
  • NP_055689.1:p.Met376Val
  • LRG_255t1:c.1126A>G
  • LRG_255:g.26889A>G
  • LRG_255p1:p.Met376Val
  • NC_000001.10:g.12062126A>G
  • NM_014874.3:c.1126A>G
Protein change:
M376V
Links:
dbSNP: rs863224967
NCBI 1000 Genomes Browser:
rs863224967
Molecular consequence:
  • NM_001127660.2:c.1126A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_014874.4:c.1126A>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Charcot-Marie-Tooth disease type 2A2
Synonyms:
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A2; HEREDITARY MOTOR AND SENSORY NEUROPATHY IIA2; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0012231; MedGen: C4721887; Orphanet: 99947; OMIM: 609260

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV0023189053billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 22, 2022)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1not providedclinical testing

Citations

PubMed

MFN2-related genetic and clinical features in a cohort of Chinese CMT2 patients.

Xie Y, Li X, Liu L, Hu Z, Huang S, Zhan Y, Zi X, Xia K, Tang B, Zhang R.

J Peripher Nerv Syst. 2016 Mar;21(1):38-44. doi: 10.1111/jns.12159.

PubMed [citation]
PMID:
26801520

Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).

Engelfried K, Vorgerd M, Hagedorn M, Haas G, Gilles J, Epplen JT, Meins M.

BMC Med Genet. 2006 Jun 8;7:53.

PubMed [citation]
PMID:
16762064
PMCID:
PMC1524942
See all PubMed Citations (10)

Details of each submission

From 3billion, SCV002318905.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (10)

Description

Same or different nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000217161). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 19889647, 22926664, 26801520, 22492563, 22851605, 28251916). Different missense changes at the same codon have been reported to be associated with MFN2 related disorder (PMID:16835246,24957169,16762064). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.794>=0.6, 3CNET: 0.806>=0.75). A missense variant is a common mechanism. It is not observed in the gnomAD v2.1.1 dataset. Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Nov 3, 2024